Fortrea Holdings Inc (FTRE)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4.87k | 75.37k | Derivative Exercise and Sale | 15.49 | 80.66k | - |
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6.14k | 0.00 | Derivative Exercise and Retained Stock | - | 80.66k | 8.24% |
| 2026-06-01 | Ms. Jill McConnellCFO | -4.87k | 75.37k | Derivative Exercise and Sale | 15.49 | 78.42k | - |
| 2026-06-01 | Ms. Jill McConnellCFO | 6.14k | 0.00 | Derivative Exercise and Retained Stock | - | 78.42k | 8.50% |
| 2026-05-18 | Mr. Robert ParksCAO | -2.00k | 26.88k | 売り | 13.44 | 20.39k | -8.93% |
| 2026-05-14 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 148.54k | 0.00 | Derivative Exercise and Retained Stock | - | 246.67k | 151.36% |
| 2026-03-20 | Ms. Erin L. RussellIndependent Director | 23.95k | 0.00 | Derivative Exercise and Retained Stock | - | 33.80k | 243.01% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | 2.48k | 0.00 | Derivative Exercise and Retained Stock | - | 74.52k | 3.44% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1.80k | 16.63k | Derivative Exercise and Sale | 9.22 | 74.52k | - |
| 2026-03-13 | Ms. Jill McConnellCFO | 2.48k | 0.00 | Derivative Exercise and Retained Stock | - | 72.28k | 3.55% |
| 2026-03-13 | Ms. Jill McConnellCFO | -1.80k | 16.63k | Derivative Exercise and Sale | 9.22 | 72.28k | - |
| 2026-03-09 | Mr. Robert ParksCAO | 3.34k | 0.00 | Derivative Exercise and Retained Stock | - | 22.39k | 17.55% |
| 2026-03-09 | Mr. Robert ParksCAO | -1.93k | 17.48k | Derivative Exercise and Sale | 8.93 - 9.21 | 22.39k | - |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 9.37k | 0.00 | Derivative Exercise and Retained Stock | - | 72.04k | 14.94% |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4.60k | 41.71k | Derivative Exercise and Sale | 8.93 - 9.21 | 72.04k | - |
| 2026-03-09 | Ms. Jill McConnellCFO | 10.22k | 0.00 | Derivative Exercise and Retained Stock | - | 69.80k | 17.16% |
| 2026-03-09 | Ms. Jill McConnellCFO | -5.06k | 45.90k | Derivative Exercise and Sale | 8.93 - 9.21 | 69.80k | - |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 1.08k | 0.00 | Derivative Exercise and Retained Stock | - | 62.68k | 1.75% |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1.18k | 16.36k | Derivative Exercise and Sale | 13.65 - 14.11 | 62.68k | - |
| 2026-02-09 | Ms. Jill McConnellCFO | 804.00 | 0.00 | Derivative Exercise and Retained Stock | - | 59.57k | 1.37% |
| 2026-02-09 | Ms. Jill McConnellCFO | -881.00 | 12.23k | Derivative Exercise and Sale | 13.65 - 14.11 | 59.57k | - |
| 2025-09-15 | Mr. Robert ParksCAO | 17.60k | 0.00 | Derivative Exercise and Retained Stock | - | 19.05k | 1,213.52% |
| 2025-09-15 | Mr. Robert ParksCAO | -7.34k | 73.01k | Derivative Exercise and Sale | 9.95 | 19.05k | - |
| 2025-09-08 | Mr. Robert ParksCAO | 1.45k | 0.00 | Derivative Exercise and Retained Stock | - | 1.45k | - |
| 2025-09-08 | Mr. Robert ParksCAO | -592.00 | 6.06k | Derivative Exercise and Sale | 10.23 | 1.45k | - |
| 2025-09-08 | Mr. James Stillman Hansonインサイダー | 4.11k | 0.00 | Derivative Exercise and Retained Stock | - | 19.09k | 27.44% |
| 2025-09-08 | Mr. James Stillman Hansonインサイダー | -1.68k | 17.16k | Derivative Exercise and Sale | 10.23 | 19.09k | - |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | 4.00k | 0.00 | Derivative Exercise and Retained Stock | - | 61.60k | 6.95% |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | -3.16k | 32.28k | Derivative Exercise and Sale | 10.23 | 61.60k | - |
| 2025-09-08 | Ms. Jill McConnellCFO | 4.00k | 0.00 | Derivative Exercise and Retained Stock | - | 58.77k | 7.30% |
| 2025-09-08 | Ms. Jill McConnellCFO | -3.16k | 32.29k | Derivative Exercise and Sale | 10.23 | 58.77k | - |
| 2025-09-02 | Ms. Erin L. RussellIndependent Director | 9.85k | 100.02k | 買い | 10.15 | 9.85k | - |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6.43k | 0.00 | Derivative Exercise and Retained Stock | - | 57.60k | 12.56% |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4.89k | 39.14k | Derivative Exercise and Sale | 8.01 | 57.60k | - |
| 2025-08-18 | Ms. Jill McConnellCFO | 6.43k | 0.00 | Derivative Exercise and Retained Stock | - | 54.77k | 13.29% |
| 2025-08-18 | Ms. Jill McConnellCFO | -4.89k | 39.14k | Derivative Exercise and Sale | 8.01 | 54.77k | - |
| 2025-08-08 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 62.50k | 407.15k | 買い | 6.26 - 6.79 | 98.13k | 175.40% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。